Morgan Stanley Keeps Their Hold Rating on Metlife (MET)


In a report released today, Nigel Dally from Morgan Stanley maintained a Hold rating on Metlife (MET), with a price target of $54. The company’s shares closed yesterday at $44.73.

According to TipRanks.com, Dally is a 4-star analyst with an average return of 13.7% and a 62.9% success rate. Dally covers the Financial sector, focusing on stocks such as Brighthouse Financial Inc, Prudential Financial Inc, and Lincoln National Corp.

Currently, the analyst consensus on Metlife is a Hold with an average price target of $52, a 16.3% upside from current levels. In a report issued on November 2, UBS also maintained a Hold rating on the stock with a $46 price target.

.

See today’s analyst top recommended stocks >>

Based on Metlife’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $16.58 billion and net profit of $912 million. In comparison, last year the company earned revenue of $16.24 billion and had a GAAP net loss of $81 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MetLife, Inc. provides insurance and financial services to individual and institutional customers. It offers life insurance, annuities, automobile and homeowner’s insurance and retail banking services to individuals as well as group insurance, reinsurance and retirement and savings products and services.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts